Linking to your own regurgitated fluff doesn't help you make a point.
With a disease for which a patients life expectancy is 14 months (all GBM patients, not this cherry picked group), delaying releasing data for longer than this life expectancy is evil unless of course LP knows patients wouldn't be getting anything better than SOC anyway with DCVax.
You do understand how despicable it would be to delay life saving treatment (if it actually was) for a year and half (or infinitely as will most likely be the case) so they can time it with a publication, right?
Market Data 
Markets 
AI
